SARS-CoV-2感染与疫苗接种对生育及辅助生殖技术结局影响的伞状综述
结果显示COVID-19感染可能降低男性精液质量(精液量、精子总数、浓度、活力和总 motility),即使康复超过90天后精子浓度和活力仍低于未感染者;对女性卵巢储备和ART结局影响甚微;疫苗接种对两性生育影响均很小。证据质量普遍极低。
要点
- COVID-19感染可能降低男性精液量、精子总数、浓度、活力和总 motility。
- 感染康复超过90天后,精子浓度和活力仍低于未感染者。
- 女性卵巢储备和ART结局受感染影响甚微,疫苗接种对两性生育影响很小。
核心结论
- SARS-CoV-2感染主要影响男性生育力,导致精子质量、数量和活力下降。
- 女性生育力和ART结局几乎不受影响,COVID-19疫苗接种对生育和ART结局影响甚微。
- 证据质量评级为极低至低,需要高质量前瞻性长期随访研究。
研究设计与样本
- 共识别647项研究,最终纳入14项研究,涵盖40个结局。
- 采用AMSTAR和GRADE工具评估证据质量。
主要发现
- COVID-19感染降低精液量(WMD -0.48 ml;95%CI -0.59至-0.36 ml)。
- 降低精子总数(WMD -34.84×10^6;95%CI -43.51至-26.17×10^6)和精子浓度(WMD -16.23×10^6/ml;95%CI -25.56×10^6至-6.89×10^6/ml)。
- 降低精子活力(SMD -0.66;95%CI -1.27至-0.06)和总精子 motility(SMD -0.61;95%CI -0.96至-0.25)。
- 升高雌二醇(SMD 0.652;95%CI 0.254至1.049;p=0.001)和催乳素(SMD 0.305;95%CI 0.045至0.566;p=0.022),睾酮无显著影响。
- 康复超过90天后精子浓度和活力仍低于未感染者;女性卵巢储备和ART结局影响甚微;疫苗接种对两性影响很小。
临床怎么用
- 对男性COVID-19感染者,尤其是备孕人群,可考虑评估精液质量。
- 康复超过90天后仍可能存在精子参数下降,需长期随访。
- 疫苗接种对生育和ART结局影响甚微,可支持接种建议。
局限性
- 纳入研究证据质量普遍极低至低。
- 需要高质量前瞻性研究及更长随访期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive technology (ART) outcomes. STUDY DESIGN: This is an Umbrella Review of Meta-analyses. We searched major databases until December 30, 2023. The quality of evidence was assessed by a Measurement Tool to Assess Systematic Reviews and the Grading of Recommendations, Assessment, Development and Evaluation. RESULTS: Of 647 studies identified, 14 studies with 40 outcomes were included. COVID-19 infection may decrease semen quality in men, including semen volume (WMD, -0.48 ml; 95% CI, -0.59 to -0.36 ml), total sperm count (WMD, -34.84 × 10^6; 95% CI, -43.51 to -26.17 × 10^6), sperm concentration (WMD, -16.23 × 10^6/ml; 95% CI, -25.56 × 10^6 to -6.89 × 10^6), viability (SMD, -0.66; 95% CI, -1.27 to -0.06), and total sperm motility (SMD, -0.61; 95% CI, -0.96 to -0.25), and elevated levels of estradiol (SMD 0.652; 95% CI, 0.254 to 1.049; p = 0.001) and prolactin (SMD 0.305; 95% CI, 0.045 to 0.566; p = 0.022). However, it did not significantly affect testosterone levels. Notably, even after recovery (over 90 days), sperm concentration and motility remained lower compared to uninfected individuals. Conversely, COVID-19 showed minimal impact on female ovarian reserve (including antral follicle count, AMH) or ART outcomes (including oocyte number and quality, embryo quality, implantation rates, clinical pregnancy rates and miscarriage rates). Vaccination also had minimal effects on both sexes. Evidence quality was generally very low, highlighting the need for high-quality, long-term studies. CONCLUSION: SARS-CoV-2 infection primarily affects male fertility, leading to reductions in sperm quality, count, and motility. However, female fertility and ART outcomes show little to no impact. COVID-19 vaccination shows minimal impact on fertility and ART outcomes. The quality of evidence is rated as very low to low. High-quality prospective studies with longer follow-up periods are needed.
引用
- Cao Q, Du S, Yang K, et al. Assessing the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive techniques outcomes: an umbrella review. Vaccine. 2026. PMID: 41666787. doi:10.1016/j.vaccine.2026.128293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。